NO891122D0 - Platinakoordinasjonsforbindelser og anvendelse av forbindelsene i kjemoterapi. - Google Patents

Platinakoordinasjonsforbindelser og anvendelse av forbindelsene i kjemoterapi.

Info

Publication number
NO891122D0
NO891122D0 NO891122A NO891122A NO891122D0 NO 891122 D0 NO891122 D0 NO 891122D0 NO 891122 A NO891122 A NO 891122A NO 891122 A NO891122 A NO 891122A NO 891122 D0 NO891122 D0 NO 891122D0
Authority
NO
Norway
Prior art keywords
compounds
platino
chemical therapy
coordination
coordination compounds
Prior art date
Application number
NO891122A
Other languages
English (en)
Other versions
NO891122L (no
Inventor
Kenneth Reginald Haarap
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Publication of NO891122D0 publication Critical patent/NO891122D0/no
Publication of NO891122L publication Critical patent/NO891122L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO89891122A 1988-03-16 1989-03-15 Platinakoordinasjonsforbindelser og anvendelse av forbindelsene i kjemoterapi. NO891122L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888806224A GB8806224D0 (en) 1988-03-16 1988-03-16 Platinum chemotherapeutic product

Publications (2)

Publication Number Publication Date
NO891122D0 true NO891122D0 (no) 1989-03-15
NO891122L NO891122L (no) 1989-09-18

Family

ID=10633521

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89891122A NO891122L (no) 1988-03-16 1989-03-15 Platinakoordinasjonsforbindelser og anvendelse av forbindelsene i kjemoterapi.

Country Status (13)

Country Link
US (1) US4892735A (no)
EP (1) EP0339772A1 (no)
JP (1) JPH0296523A (no)
KR (1) KR890014107A (no)
AU (1) AU613720B2 (no)
DK (1) DK105889A (no)
FI (1) FI890951A (no)
GB (1) GB8806224D0 (no)
IL (1) IL89502A0 (no)
NO (1) NO891122L (no)
NZ (1) NZ228267A (no)
PT (1) PT90027A (no)
ZA (1) ZA891524B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0405617A3 (en) * 1985-03-14 1992-11-25 Beecham Group P.L.C. Medicaments for the treatment of anxiety
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
FR2698871B1 (fr) 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
EP0937460A3 (en) * 1994-04-12 2000-04-05 Adolor Corporation Use of an antidiarrheal for the manufacture of a medicament for the treatment of inflammatory conditions
JP3492763B2 (ja) 1994-06-03 2004-02-03 エスエス製薬株式会社 白金錯体及びこれを含有する悪性腫瘍治療剤
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
AUPQ641100A0 (en) * 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
KR20040048900A (ko) * 2001-09-24 2004-06-10 토스크, 인코포레이티드 감소된 독성 시스플라틴 포뮬레이션 및 이의 이용 방법
ES2278115T3 (es) 2003-10-13 2007-08-01 Zoser B. Nat.Rer.Dr. Salama Composicion farmaceutica que comprende oxoplatino y sus sales.
US8956161B2 (en) * 2008-11-04 2015-02-17 Duane C Keller Article and method for controlling oral-originated systemic disease

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714159A (en) * 1971-03-30 1973-01-30 Janssen Pharmaceutica Nv 2,2-diaryl-4-(4'-aryl-4'-hydroxy-piper-idino)-butyramides
US4175133A (en) * 1977-02-18 1979-11-20 United States Of America 1,2-Diaminocyclohexane platinum (II) complexes having antineoplastic activity against L1210 leukemia
US4116963A (en) * 1977-05-23 1978-09-26 G.D. Searle & Co. 3,3,3-triarylalkyl-4-phenylalkyl-4-hydroxy piperidines and related compounds
US4194045A (en) * 1977-12-27 1980-03-18 G. D. Searle & Co. 1-(3,3-Diaryl-3-oxadiazolalkyl)-4-phenyl-4-piperidinomethanols and related compounds
CA1158558A (en) * 1980-05-27 1983-12-13 Terence J. Ward Antidiarrhoeal agents
US4536386B1 (en) * 1981-01-26 1995-03-07 Robins Co Inc A H Method of controlling emesis caused by cisplatin in cancer chemotherapy
GB8328218D0 (en) * 1983-10-21 1983-11-23 Johnson Matthey Plc Oral compositions
US4599352A (en) * 1984-03-01 1986-07-08 The United States Of America As Represented By The Department Of Health And Human Services Antineoplastic platinum (IV) complexes and compositions
EP0405617A3 (en) * 1985-03-14 1992-11-25 Beecham Group P.L.C. Medicaments for the treatment of anxiety
GB8515845D0 (en) * 1985-06-22 1985-07-24 Beecham Group Plc Treatment
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
US4793986A (en) * 1987-02-25 1988-12-27 Johnson Matthey, Inc. Macromolecular platinum antitumor compounds

Also Published As

Publication number Publication date
KR890014107A (ko) 1989-10-21
EP0339772A1 (en) 1989-11-02
PT90027A (pt) 1989-11-10
JPH0296523A (ja) 1990-04-09
DK105889A (da) 1989-09-17
NO891122L (no) 1989-09-18
NZ228267A (en) 1990-12-21
ZA891524B (en) 1989-10-25
DK105889D0 (da) 1989-03-06
FI890951A (fi) 1989-09-17
FI890951A0 (fi) 1989-02-28
AU3112789A (en) 1989-09-21
GB8806224D0 (en) 1988-04-13
IL89502A0 (en) 1989-09-10
US4892735A (en) 1990-01-09
AU613720B2 (en) 1991-08-08

Similar Documents

Publication Publication Date Title
NO894587D0 (no) Glassblanding for anvendelse i glasur og emalje.
NO890086D0 (no) Broennbehandlingsvaeske og tilsetningsmiddel.
FI894956A0 (fi) Sjaelvexpanderande flexibel paose.
ATE120194T1 (de) Therapeutische nuleoside.
FI903656A0 (fi) Terapeutiska kinuklidinfoereningar.
DE58907575D1 (de) Strahlentherapiegerät.
NO910031L (no) Immunkonjugater for cancerdiagnostikk og terapi.
DE68920754D1 (de) Baugerät und Bauverfahren.
NO885067D0 (no) Blandeapparat.
NO891122D0 (no) Platinakoordinasjonsforbindelser og anvendelse av forbindelsene i kjemoterapi.
FI894648A (fi) Kemiska foereningar.
FI893897A (fi) Terapeutiska nukleosider.
NO894350L (no) Pyrrolokinolin- og pyrrolofenotiazinkarboksamider og beslektede forbindelser.
DE3672598D1 (de) Fungizide mit triazol- und oligoaethergruppen und mischungen.
FI890896A (fi) Extremt flexibel polypropenfiber.
ES1010073Y (es) Recipiente portatil.
NO894187D0 (no) Terapeutiske forbindelser.
NO890522L (no) Substituerte imidazolinoner og imidazolinthioner.
FI911554A0 (fi) Kemiska formulationer.
FI892782A0 (fi) Foerfarande foer tillverkning av flexibel polyuretanskumplast.
DK396089A (da) 6-aroyl-substituerede 3,4-dihydro-2h-benzopyraner samt fremstilling og anvendelse deraf
FI851796A0 (fi) Kamflaenskonstruktion foer fastsaettning av tvao in i varandra placerbara roerformiga stycken.
DK338989D0 (da) Lipasegen og anvendelse deraf
BR6802583U (pt) Disposicao introduzida em agenda
ES1006440Y (es) Plantilla terapeutica.